Hebei Changshan Biochemical Pharmaceutical Co., Ltd. (SHE:300255)
China · Delayed Price · Currency is CNY 44.03
+0.24 (0.55%)
Jul 18, 2025, 3:09 PM CST
Hebei Changshan Biochemical Pharmaceutical Company Description
Hebei Changshan Biochemical Pharmaceutical Co., Ltd. engages in the research, development, production, and sale of crude heparin, heparin raw materials, and heparin preparations for the treatment of cardiovascular and cerebrovascular diseases in China and internationally.
It offers crude heparin sodium, heparin sodium raw materials, heparin sodium injections, low molecular weight heparin calcium raw materials and injections, enoxaparin sodium raw materials and injections, nadri heparin calcium API, nandroparin calcium injection, and dalteparin sodium API and injection.
The company was founded in 2000 and is based in Shijiazhuang, China.
Hebei Changshan Biochemical Pharmaceutical Co., Ltd.
| Country | China |
| Founded | 2000 |
| Industry | Biotechnology |
| Sector | Healthcare |
| Employees | 1,254 |
| CEO | Xiaodong Gao |
Contact Details
Address: Zhengding High-tech Industrial Development Zone Shijiazhuang, Hebei Province 050800 China | |
| Phone | 86 311 8919 0181 |
| Website | hbcsbio.com |
Stock Details
| Ticker Symbol | 300255 |
| Exchange | Shenzhen Stock Exchange |
| Fiscal Year | January - December |
| Reporting Currency | CNY |
| ISIN Number | CNE1000016C2 |
| SIC Code | 2834 |
Key Executives
| Name | Position |
|---|---|
| Xiaodong Gao | Chairman of the Board and GM |
| Xiaohua Yue | Deputy GM and Chief Financial Officer |
| Yunxia Sun | Deputy GM and Non-Independent Director |
| Zhenggang Qie | Deputy GM and Non-Independent Director |
| Zhihua Li | Deputy General Manager |
| Qing Zhang | Deputy General Manager |
| Xnjun Zhang | Deputy General Manager |
| Zhang Tao | Deputy General Manager |